Company / Net Debt per Share
10x Genomics, Inc. Net Debt per Share History
FY2018-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$6.90
FY2020
5-year range
-
FY2018-FY2020
Trend
+74.6%
vs FY2019
Sector context
#94 of 100
Health Care
What the data says
Among 100 Health Care companies, 10x Genomics, Inc. is in the top 6% for net debt per share. Improved from $-2.96 to $-6.90 over the past 2 years.
Based on SEC 10-K filings.
-6.90 in FY2020.
Improved from $-2.96 to $-6.90 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 100This company -$6.90 Sector average $7.63
▼
-190.4% below sector average
Key checks
Key Insights
- In FY2020, net debt per share increased 74.6% year-over-year.
- Ranks #94 out of 100 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.94 (distress zone, below 1.8 threshold)
- Negative profit margin: -29.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | -$6.90 | +74.6% |
| FY2019 | -$27.11 | -817.0% |
| FY2018 | -$2.96 | - |
| FY2017 | - | - |
As of FY2020 · SEC 10-K · Updated Feb 28, 2026